Soteria Biotherapeutics, Inc. — Form D

Soteria Biotherapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-17. The offering totals $42.2M, of which $24.9M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-05-17
• Form: D
• Accession: 0001862212-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $42.2M
• Amount sold: $24.9M
• Remaining: $17.3M
• Investors: 8
• Date of first sale: 2021-05-04
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-399644

Issuer

• Name: Soteria Biotherapeutics, Inc.
• CIK: 0001862212
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 953 INDIANA ST., SAN FRANCISCO, CA, 94107
• Phone: 415-514-4498

Officers, directors & promoters (10)

More

• CIK 1862212 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search